Intuitive Surgical, Inc. (NASDAQ:ISRG) Stake Cut by Meeder Asset Management Inc.

Meeder Asset Management Inc. cut its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 88.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 96 shares of the medical equipment provider’s stock after selling 743 shares during the period. Meeder Asset Management Inc.’s holdings in Intuitive Surgical were worth $43,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Creekmur Asset Management LLC raised its stake in shares of Intuitive Surgical by 200.0% in the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 42 shares in the last quarter. Ridgewood Investments LLC bought a new position in shares of Intuitive Surgical in the 2nd quarter valued at approximately $26,000. Able Wealth Management LLC bought a new position in shares of Intuitive Surgical in the 4th quarter valued at approximately $28,000. Delos Wealth Advisors LLC raised its stake in shares of Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 57 shares in the last quarter. Finally, LRI Investments LLC bought a new position in shares of Intuitive Surgical in the 1st quarter valued at approximately $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

ISRG opened at $489.86 on Monday. Intuitive Surgical, Inc. has a one year low of $254.85 and a one year high of $496.18. The company’s 50 day simple moving average is $463.74 and its 200-day simple moving average is $422.04. The stock has a market capitalization of $173.75 billion, a P/E ratio of 88.42, a price-to-earnings-growth ratio of 5.41 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, beating the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The business had revenue of $2.01 billion for the quarter, compared to analysts’ expectations of $1.97 billion. During the same period in the prior year, the firm earned $1.18 earnings per share. Intuitive Surgical’s revenue was up 14.5% compared to the same quarter last year. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 5.22 EPS for the current year.

Analyst Ratings Changes

A number of brokerages recently weighed in on ISRG. The Goldman Sachs Group began coverage on Intuitive Surgical in a research note on Thursday, May 30th. They issued a “buy” rating and a $500.00 price objective on the stock. Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and raised their price objective for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. Piper Sandler raised their price objective on shares of Intuitive Surgical from $490.00 to $495.00 and gave the stock an “overweight” rating in a research note on Friday, July 19th. Citigroup raised their price target on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Finally, JPMorgan Chase & Co. increased their price target on shares of Intuitive Surgical from $475.00 to $495.00 and gave the stock an “overweight” rating in a research report on Friday, July 19th. Six research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $446.45.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Craig H. Barratt sold 1,400 shares of the firm’s stock in a transaction that occurred on Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total value of $641,382.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other Intuitive Surgical news, EVP Robert Desantis sold 238 shares of the firm’s stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $477.50, for a total value of $113,645.00. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,629,115. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Craig H. Barratt sold 1,400 shares of the firm’s stock in a transaction that occurred on Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total transaction of $641,382.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 50,555 shares of company stock valued at $24,267,737. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.